I Gilyazova1,2, E Ivanova3, G Gilyazova2, I Sultanov2, A Izmailov2, R Safiullin2, V Pavlov2, E Khusnutdinova1,2. 1. Institute of Biochemistry and Genetics - Subdivision, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russian Federation, 450054. 2. Bashkir State Medical University, Ufa, Russian Federation, 450008. 3. Institute of Biochemistry and Genetics - Subdivision, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russian Federation, 450054. lissa987@yandex.ru.
Abstract
BACKGROUND: Renal cell carcinoma is the most common form of kidney cancer in adults. DNA methylation of regulatory sequences at the genomic level and interaction between microRNAs and the messenger RNAs of target genes at the posttranscriptional level contribute to the dynamic regulation of gene activity. Aberrations in these mechanisms can result in impaired functioning of cell signaling pathways, such as that observed in malignant tumors. We hypothesized that microRNA genes methylation may be associated with renal cancer in patients. METHODS AND RESULTS: We examined methylation levels of 22 microRNA genes in tumor and normal kidney tissue of 30 patients with TNM Stage III clear cell renal cell carcinoma using a pathway-specific real-time polymerase chain reaction array (EpiTect Methyl II PCR Arrays, Qiagen). MicroRNA expression analysis by quantitative polymerase chain reaction was also performed. Significant differences in methylation levels were found in two genes and in two clusters of microRNA genes. MicroRNA-23b/-24-1/-27b, microRNA -30c-1/-30e and let-7 g was hypermetylated in clear cell renal cell carcinoma tissue, microRNA -301a was hypomethylated in tumor compared with the adjacent normal tissues. Expression of microRNA-301a, microRNA-23b in the clear cell renal cell carcinoma tissues was significantly overexpressed when compared with the adjacent normal tissues and let-7 g was significantly downregulated in tumor. CONCLUSIONS: Our results may indicate the contribution of microRNA-301a, microRNA-23b and let-7 g in the pathogenesis of renal cancer, but further studies are needed to determine the functional significance of the detected changes.
BACKGROUND:Renal cell carcinoma is the most common form of kidney cancer in adults. DNA methylation of regulatory sequences at the genomic level and interaction between microRNAs and the messenger RNAs of target genes at the posttranscriptional level contribute to the dynamic regulation of gene activity. Aberrations in these mechanisms can result in impaired functioning of cell signaling pathways, such as that observed in malignant tumors. We hypothesized that microRNA genes methylation may be associated with renal cancer in patients. METHODS AND RESULTS: We examined methylation levels of 22 microRNA genes in tumor and normal kidney tissue of 30 patients with TNM Stage III clear cell renal cell carcinoma using a pathway-specific real-time polymerase chain reaction array (EpiTect Methyl II PCR Arrays, Qiagen). MicroRNA expression analysis by quantitative polymerase chain reaction was also performed. Significant differences in methylation levels were found in two genes and in two clusters of microRNA genes. MicroRNA-23b/-24-1/-27b, microRNA -30c-1/-30e and let-7 g was hypermetylated in clear cell renal cell carcinoma tissue, microRNA -301a was hypomethylated in tumor compared with the adjacent normal tissues. Expression of microRNA-301a, microRNA-23b in the clear cell renal cell carcinoma tissues was significantly overexpressed when compared with the adjacent normal tissues and let-7 g was significantly downregulated in tumor. CONCLUSIONS: Our results may indicate the contribution of microRNA-301a, microRNA-23b and let-7 g in the pathogenesis of renal cancer, but further studies are needed to determine the functional significance of the detected changes.
Authors: Miriam Schiffgen; Doris H Schmidt; Alexander von Rücker; Stefan C Müller; Jörg Ellinger Journal: Biochem Biophys Res Commun Date: 2013-05-22 Impact factor: 3.575
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Tzu-Pin Shentu; Tse-Shun Huang; Mateja Cernelc-Kohan; Joy Chan; Simon S Wong; Celia R Espinoza; Chunting Tan; Irene Gramaglia; Henri van der Heyde; Shu Chien; James S Hagood Journal: Sci Rep Date: 2017-12-22 Impact factor: 4.996
Authors: Lucía Trilla-Fuertes; Natalia Miranda; Daniel Castellano; Rocío López-Vacas; Carlos A Farfán Tello; Guillermo de Velasco; Felipe Villacampa; Elena López-Camacho; Guillermo Prado-Vázquez; Andrea Zapater-Moros; Enrique Espinosa; Juan Ángel Fresno Vara; Álvaro Pinto; Angelo Gámez-Pozo Journal: PLoS One Date: 2020-02-28 Impact factor: 3.240
Authors: Iver Nordentoft; Karin Birkenkamp-Demtroder; Mads Agerbæk; Dan Theodorescu; Marie Stampe Ostenfeld; Arndt Hartmann; Michael Borre; Torben F Ørntoft; Lars Dyrskjøt Journal: BMC Med Genomics Date: 2012-09-06 Impact factor: 3.063